Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 88-95

  Shen, Jia ^a   Zhang, Hongyin ^b   Lin, Han ^a   Su, Hui ^a   Xing, Dongming ^a   Du, Lijun ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Ministry of Education Beijing   (China)

Author keywords

Brazilein; Inflammation; Transient focal cerebral ischemia reperfusion

Indexed keywords

BRAZILEIN; CAESALPINIA SAPPAN EXTRACT; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL LINE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOPYRANS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CYTOKINES; INDENES; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER;

EID: 33847301419     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.059     Document Type: Article

References (24)

1. Bae I.K., Min H.Y., Han A.R., Seo E.K., and Lee S.K. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells. Eur. J. Pharmacol. 513 (2005) 237-242
2. Barnes P.J., and Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
3. Belayev L., Alonso O.F., Busto R., Zhao W., and Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke 27 (1996) 1616-1622
4. Connolly Jr. E.S., Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stern D.M., Solomon R.A., Gutierrez-Ramos J.C., and Pinsky D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97 (1996) 209-216
5. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397
6. Endres M., Laufs U., Liao J.K., and Moskowitz M.A. Targeting eNOS for stroke protection. Trends Neurosci. 27 (2004) 283-289
7. Feigin V.L., Lawes C.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2 (2003) 43-53
8. Hu C.M., Kang J.J., Lee C.C., Li C.H., Liao J.W., and Cheng Y.W. Induction of vasorelaxation through activation of nitric oxide synthase in endothelial cells by brazilin. Eur. J. Pharmacol. 468 (2003) 37-45
9. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139
10. Iadecola C., Zhang F.Y., Casey R., Nagayama M., and Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17 (1997) 9157-9164
11. Iadecola C., Salkowski C.A., Zhang F.Y., Aber T., Nagayama M., Vogel S.N., and Ross M.E. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. J. Exp. Med. 189 (1999) 719-727
12. Li H., and Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190 (2000) 244-245
13. Li Q., and Verma I.M. NF-kappa B regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
14. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
15. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
16. Mahajan S.K., Kashyap R., Sood B.R., Jaret P., Mokta J., Kaushik N.K., and Prashar B.S. Stroke at moderate altitude. J. Assoc. Phys. India 52 (2004) 699-702
17. Mokudai T., Ayoub I.A., Sakakibara Y., Lee E.J., Ogilvy C.S., and Maynard K.I. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 31 (2000) 1679-1685
18. Nagai M., Nagumo S., Leee S.M., Eguchi I., and Kawai K.I. Protosappanin A, a novel biphenyl compound from sappan lignum. Chem. Pharm. Bull. 34 (1986) 1-7
19. Oliveira L.F.C., Edwards H.G.M., Velozo E.S., and Nesbitt M. Vibrational spectroscopic study of brazilin and brazilein, the main constituents of brazilwood from Brazil. Vib. Spectrosc. 28 (2002) 243-249
20. Sarti C., Rastenyte D., Cepaitis Z., and Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 31 (2000) 1588-1601
21. Silvestrelli G., Corea F., Paciaroni M., Milia P., Palmerini F., Parnetti L., and Gallai V. The Perugia hospital-based Stroke Registry: report of the 2nd year. Clin. Exp. Hypertens. 24 (2002) 485-491
22. WHO. The world health report 2000 (2000), WHO, Geneva
23. Ye M., Xie W.D., Lei F., Meng Z., Zhao Y.N., Su H., and Du L.J. Brazilein, an important immunosuppressive component from Caesalpinia sappan L. Int. Immunopharmacol. 6 (2006) 426-432
24. Zhao Y.N., Pan Y., Tao J.L., Xing D.M., and Du L.J. Study on cardioactive effects of Brazilein. Pharmacology 76 (2006) 76-83